On this page you can find relevant researchs on drug-related health topics, including HIV, hepatitis C, drug and overdose prevention, harm reduction and drug treatment. You can also find our Clinical Guidelines.

The Death Penalty for Drug Offences: Global Overview 2018
The death penalty for drug offences is a clear violation of international human rights law. Numerous international authorities and legal scholars have reaffirmed this point, including the UN Human Rights Committee as recently as 2018.
Safe consumption sites: Study identifies policy change strategies and challenges
A new qualitative study from the Johns Hopkins Bloomberg School of Public Health identifies several key lessons from early efforts to establish sanctioned safe consumption sites in five U.S. communities. The results offer insights on one approach some localities are exploring to address the escalating drug overdose crisis in the U.S.
Fraction of US outpatient treatment centers offer medication for opioid addiction
Study finds that most substance use disorder treatment facilities still do not offer medication treatment for opioid use disorder
THE GLOBAL STATE OF HARM REDUCTION 2018
This report was made possible by the collaborative input of harm reduction organisations networks, drug user organisations, researchers, academics and advocates.
Medically Supervised Injecting Facility
A Medically Supervised Injecting Facility (MSIF) is a healthcare facility where people can inject drugs, obtained elsewhere, under the supervision of trained health professionals.
Words matter: a call for humanizing and respectful language to describe people who experience incarceration
Words matter when describing people involved in the criminal justice system because language can have a significant impact upon health, wellbeing, and access to health information and services. However, terminology used in policies, programs, and research publications is often derogatory, stigmatizing, and dehumanizing.
Drug consumption rooms: an overview of provision and evidence.
Refreshing its overview of the use of drug consumption rooms, the European Union’s drug misuse monitoring centre says the evidence still contradicts concerns that such facilities encourage drug use, delay treatment entry, or aggravate problems arising from local drug markets – finding instead that both the users and the community stand to benefit.
Share this on: